Wanbangde Pharmaceutical Holding Group Co., Ltd. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    €171.74M -6.4% €6.60M +12.7% 3.8% +0.0065 pp €24.83M +273.6% 14.5% +0.11 pp
    €183.46M -13.7% €5.85M -33.8% 3.2% -0.0097 pp €6.65M -177.1% 3.6% +0.077 pp
    €212.55M -7.5% €8.84M -55.4% 4.2% -0.045 pp -€8.62M -124.2% -4.1% -0.20 pp
    €229.71M -85.9% €19.81M -41.6% 8.6% +0.065 pp €35.59M -57.9% 15.5% +0.10 pp
    €1.63B -13.3% €33.90M +81.5% 2.1% +0.011 pp €84.51M +351.6% 5.2% +0.042 pp
    €1.88B +10.2% €18.68M +86.8% 1.0% +0.0041 pp €18.71M -53.1% 1.0% -0.013 pp
    €1.71B -2.1% €10.00M -14.4% 0.6% -0.00085 pp €39.86M +10,119.9% 2.3% +0.023 pp
    €1.74B +59.4% €11.69M +40.8% 0.7% -0.00088 pp €390.05K -99.0% 0.0% -0.035 pp
    €1.09B -20.6% €8.30M +10.6% 0.8% +0.0021 pp €38.04M +577.0% 3.5% +0.031 pp
    €1.38B +1.1% €7.50M -41.4% 0.5% -0.0039 pp €5.62M -74.5% 0.4% -0.012 pp
    €1.36B -2.8% €12.79M -3.6% 0.9% -0.000075 pp €22.04M -25.0% 1.6% -0.0048 pp
    €1.40B +7.4% €13.27M +29.1% 0.9% +0.0016 pp €29.37M +1.3% 2.1% -0.0013 pp
    €1.31B +0.9% €10.28M -45.5% 0.8% -0.0067 pp €28.99M +83.4% 2.2% +0.010 pp
    €1.29B +35.0% €18.88M +4.4% 1.5% -0.0043 pp €15.81M -35.6% 1.2% -0.013 pp
    €958.25M +26.9% €18.08M +25.6% 1.9% -0.00020 pp €24.54M +61.0% 2.6% +0.0054 pp
    €755.27M +8.8% €14.40M +63.5% 1.9% +0.0064 pp €15.25M -68.0% 2.0% -0.048 pp
    €694.37M +19.3% €8.81M +16.4% 1.3% -0.00032 pp €47.59M +227.5% 6.9% +0.044 pp
    €582.01M +30.8% €7.57M +93.7% 1.3% +0.0042 pp €14.53M +26.0% 2.5% -0.00097 pp
    €444.87M +218.8% €3.91M +53.6% 0.9% -0.0094 pp €11.54M -2.1% 2.6% -0.059 pp
    €139.52M +119.0% €2.54M -16.7% 1.8% -0.030 pp €11.79M -24.4% 8.4% -0.16 pp
    €63.71M +28.7% €3.05M +26.9% 4.8% -0.00069 pp €15.59M +74.8% 24.5% +0.065 pp
    €49.50M €2.41M 4.9% €8.91M 18.0%

    Notifications